Este post é de um grupo sugerido
Overcoming Biological Barriers in Nucleic Acid Therapeutics
Administering nucleic acid therapeutics requires overcoming several biological barriers. The human body is naturally designed to break down foreign genetic material, making stability and protection essential.
The first barrier is enzymatic degradation in the bloodstream. Chemical modifications to nucleic acids improve durability and resistance. The second barrier is cellular uptake. Cells typically do not allow large molecules to enter easily, so delivery systems like nanoparticles or viral vectors enhance entry.
Once inside the cell, nucleic acids must reach the correct compartment—mRNA therapies need cytoplasmic access, while gene editing tools require nuclear entry. Ensuring precise localization is crucial for therapeutic success.
Overcoming these barriers is an ongoing scientific challenge, but advancements continue pushing the boundaries of what nucleic acid therapies can achieve.
